Walk into any supplement aisle, and you'll find NAD and NMN used interchangeably, sometimes even on the same bottle. Yet they're fundamentally different molecules with very different fates once you swallow them.

If NAD is what your cells actually need, why are you being sold NMN?

The answer is biochemistry.

NAD is too large and fragile to survive your digestive system intact. NMN, its precursor, is smaller and equipped with a cellular express lane that NAD lacks.

This seemingly small distinction means the difference between a supplement that works and one that doesn't.

The confusion is understandable.

Both molecules target the same cellular pathway, i.e, the NAD+ salvage system, and both have been investigated for their potential to support healthy aging.

And while both raise measurable NAD levels in blood, the leap from "elevated NAD" to "longer, healthier life" requires honest skepticism that the current research doesn't yet support.

This article answers the specific questions you're likely asking:

• What are NAD and NMN, exactly?

• Why can you absorb one but not the other?

• What do the most recent human trials actually show?

• And if you're trying to support your NAD levels, which one should you choose?

Key Takeaways

• NAD (nicotinamide adenine dinucleotide) is the active coenzyme your cells use for energy production, DNA repair, and aging-related processes; NMN (nicotinamide mononucleotide) is a single-step metabolic precursor that your body converts into NAD.

• Oral NAD doesn't raise intracellular NAD levels because the molecule is too large and charged to cross cell membranes and breaks down in the digestive tract before absorption; direct NAD supplementation is essentially ineffective orally.

• NMN is absorbed efficiently in the small intestine, likely via a dedicated transporter, SLC12A8, though the exact mechanism is still debated. NMN then converts to NAD in a single enzymatic step (NMNAT), making it the only practical oral option for raising NAD.

• Human trials from 2024–2025 confirm NMN raises blood NAD and improves insulin sensitivity, aerobic capacity, and sleep quality at doses of 250–900 mg daily, with clear dose-response effects above 300 mg.

• IV NAD bypasses digestion but costs $250–$1,500 per session and isn't supported by outcome trials for general longevity use; it has a narrow clinical niche, not a practical daily maintenance role.

• Raising blood NAD is established; extending human lifespan has not been demonstrated in a controlled trial, and confusing these two claims is where most supplement marketing overshoots the evidence.

What Is NAD?

Think of NAD as a rechargeable cellular battery.

Your cells are constantly charging it and discharging it, using its stored energy to power thousands of biological processes every second.

Without NAD, your cells can't produce ATP (the universal energy currency), repair broken DNA, or activate proteins called sirtuins that regulate aging-related pathways.

It's not an exaggeration to say NAD is one of the most fundamental molecules in your body.

NAD exists in two forms:

• NAD+ (oxidized)

• NADH (reduced).

The plus sign indicates it's been emptied of electrons and is ready to accept them again, that's the "charging" part of the battery cycle. NADH is the charged form.

When NAD+ gains electrons, it becomes NADH. When NADH gives them up, it becomes NAD+ again. This back-and-forth happens millions of times per second in every cell you have.

NAD has three core roles

1. It's essential for ATP production in your mitochondria, the energy factories of your cells.

2. It powers DNA-repair enzymes called PARPs (poly-ADP-ribose polymerases) that fix damage from UV radiation, oxidative stress, and normal aging.

3. It activates a family of proteins called sirtuins, which are sometimes called the "longevity genes" because they regulate inflammation, metabolism, and cellular health in ways linked to aging. Shin-ichiro Imai at Washington University and David Sinclair at Harvard pioneered much of the modern research connecting NAD to sirtuin function and healthy aging.

But knowing that NAD is important and that your levels are falling raises the obvious question: can you just swallow more of it?

The short answer is no. NAD itself is what your cells need, but supplementing it directly doesn't work orally because it can not be absorbed from the gut. Its precursor form, however, can!

Why NAD Declines With Age

NAD doesn't decline uniformly across the body. Different tissues lose it at different rates, and the mechanism behind the loss is well-characterized in the research.

By midlife, NAD concentrations across most tissues drop roughly 50% compared to young adulthood. Human skin loses about 50% of its NAD through normal adult aging. Liver NAD in adults over 60 sits roughly 30% lower than in adults under 45.

In some tissues, the decline reaches 80% by age 60. Brain tissue shows a more modest 10-25% drop from young adulthood to old age, though even that smaller decline corresponds to meaningful changes in cellular function.

Two main forces drive the loss:

• Increased consumption by CD38. CD38 is an enzyme that breaks down NAD as part of immune signaling. CD38 activity rises with age, partly because of chronic low-grade inflammation (what researchers call "inflammaging"). The more CD38 your tissues produce, the faster they consume NAD. A 2016 paper in Cell Metabolism identified CD38 as a primary driver of age-related NAD decline, with knockout mice showing significantly preserved NAD levels.

• Senescent cell signaling. As cells become senescent (a state where they stop dividing but don't die), they release inflammatory signals that further activate CD38 in surrounding tissue. This creates a feedback loop: more senescence triggers more CD38, which depletes more NAD, which impairs the cellular maintenance pathways that would have cleared senescent cells in the first place.

The result is that NAD loss accelerates rather than progresses linearly.

It's also more pronounced in people with metabolic disorders, chronic inflammation, or significant cumulative oxidative damage, which is part of why NAD supplementation research has focused on these populations first.

Where NAD Comes From: The Salvage Pathway

Your body doesn't make NAD from scratch each time it's needed. Roughly 85% of cellular NAD is produced through what researchers call the salvage pathway, a recycling process that takes broken-down NAD components and rebuilds them.

The pathway works in a continuous loop. When sirtuins, PARPs, or CD38 consume NAD+, they release nicotinamide as a byproduct.

The salvage pathwaypicks up this nicotinamide, converts it into nicotinamide mononucleotide (NMN), and then converts NMN into fresh NAD+ via the enzyme NMNAT. This last step is the single enzymatic conversion that makes NMN such an efficient precursor: it sits one step away from the molecule your cells actually use.

Other minor pathways contribute to total NAD synthesis, including de novo synthesis from the amino acid tryptophan and the Preiss-Handler pathway from nicotinic acid.

But for the practical purpose of supplementing NAD levels, the salvage pathway is what matters. It's the route that supplemental NMN feeds directly.

What Is NMN?

NMN stands for nicotinamide mononucleotide. It's the immediate precursor to NAD in the metabolic route your body uses to recycle NAD and manufacture new supplies.

Once NMN is inside your cells, a single enzyme called NMNAT converts it directly to NAD+.

But the real advantage of NMN lies in how it gets into your cells in the first place. In 2019, researchers led by Grozio working in Shin-ichiro Imai's lab at Washington University identified a specific transporter protein called SLC12A8 embedded in the cells lining your small intestine.

They proposed it as a cellular door that lets NMN through directly, which is a finding that has since been both replicated and contested.

When you swallow NMN, it travels through your digestive tract and crosses into your bloodstream via this dedicated pathway.

In mouse studies, the transporter is far more concentrated in the gut than in tissues like the brain or fat. It's as if NMN has a direct express route that NAD itself doesn't have.

It's worth noting this mechanism isn't fully settled. A 2019 rebuttal argued NMN may first be converted to nicotinamide riboside before entering cells, and the question remains open.

Either way, what matters for supplement users is the downstream result: oral NMN reliably raises NAD in human blood, while oral NAD does not.

Your gut doesn't need to break it down into smaller pieces; it's small enough, and the transporter is efficient enough that it crosses intact. Once in your cells, NMNAT gets to work converting it to NAD+. The process is elegant and, most importantly for supplement consumers, it actually works.

Where does NMN come from naturally? You can find small amounts in foods like edamame, broccoli, cucumber, and avocado. But the concentrations are far below the 250–900 mg doses used in clinical trials.

You'd need to eat several pounds of these foods to get a clinically relevant dose, which is why supplementation exists.

Is NMN the Same as NAD?

No, they're not the same molecule, but they're metabolically linked. NMN is the building block your body converts into NAD.

In your cells, NAD doesn't exist in isolation. It's constantly being made and consumed. Your body manufactures about 85% of its NAD through the salvage pathway, which involves recycling old NAD molecules and building new ones from precursors like NMN.

When you supplement with NMN, you're essentially handing your cells extra raw material to feed this pathway. Your cells then perform the single enzymatic step that turns NMN into active NAD+.

This is fundamentally different from supplementing with NAD directly, where the molecule never makes it to the inside of your cells.

NMN vs NAD at a Glance

Which Has Better Bioavailability, NMN or NAD?

The comparison hinges on one fundamental property, which is whether a molecule can actually reach the inside of your cells when you swallow it. By this measure, NMN is far superior to oral NAD.

Why Oral NAD Doesn't Work Well

NAD+ is a relatively large molecule with multiple negative charges. Cell membranes are fatty barriers that are generally hostile to large, charged molecules.

NAD+ cannot cross a cell membrane on its own. It needs a transporter, and no efficient transporters for NAD exist in your small intestine.

Also, as soon as NAD enters your digestive tract, it encounters degradation. Enzymes in your stomach break it down into its component parts.

By the time any NAD reaches your intestinal epithelium, most of it has already been converted into nicotinamide, adenosine, and other breakdown products, which themselves have minimal bioavailability.

Therefore, oral NAD supplements do not raise intracellular NAD levels in any measurable way.

How NMN Gets Into Your Cells

NMN is smaller and more stable through digestion. According to preclinical studies, it remains 93–99% intact when exposed to water at room temperature for 7–10 days.

In the proposed model, the SLC12A8 transporter recognizes NMN and actively pumps it across the intestinal barrier into the bloodstream using energy.

Once in your blood, NMN enters cells through additional transporters. NMNAT then converts it to NAD+ in a single step.

This entire sequence, including efficient absorption, bloodstream transport, cellular uptake, and one-step conversion, is why oral NMN actually works.

Where IV NAD Still Has a Role

IV NAD bypasses digestion entirely, allowing NAD to enter the bloodstream directly. Blood NAD rises substantially, often 3- to 10-fold, depending on dose.

But elevated blood NAD doesn't translate to elevated intracellular NAD in the cells that matter, since NAD cannot easily cross cell membranes.

Duration is brief, and blood NAD returns toward baseline within hours once the infusion stops.

More importantly, there are essentially no eligible human outcome trials supporting IV NAD for anti-aging or wellness.

Most of the studies published on IV NAD are case reports, observational series, or small studies without control groups. IV NAD has a legitimate clinical niche under physician supervision, but not for general longevity maintenance.

What the Human Trials Actually Show

The trials give us specific evidence for specific outcomes. Here's what the science shows for the use cases we actually care about.

NMN Human Evidence (2021–2025)

Here’s some clinical trials evidence on NMN supplementation:

• Yoshino et al. (2021, Science): 250 mg NMN daily improved muscle insulin sensitivity in postmenopausal women with prediabetes, which is a meaningful metabolic improvement in an at-risk population.

• Yi et al. (2022, GeroScience): 600 mg NMN daily improved aerobic capacity with clear dose-response effects above 300 mg in healthy middle-aged adults.

• Liao et al. (2021, JISSN): NMN at 600 mg daily improved aerobic capacity in amateur runners.

• Morifuji et al. (2024, GeroScience): Older adults taking 1,000 mg NMN for 12 weeks showed elevated blood NAD, maintained walking speed, and improved sleep quality versus placebo.

• Kuerec et al. (2024, Mechanisms of Ageing and Development): Another double-blind trial that confirmed dose-response between NMN intake and NAD elevation.

• Henderson et al. (2024, NPJ Systems Biology): A systems-based approach that targeted multiple NAD pathway nodes successfully raised NAD in healthy adults.

Direct NAD Human Evidence

Outcome trials for oral direct NAD are essentially absent. The published literature is sparse compared to NMN, and nearly all focus on IV administration.

There are observational reports, small case series, and anecdotal testimonials about how IV NAD makes people "feel more energetic," but the literature does not report any controlled data.

The reason is the bioavailability problem we discussed. Oral NAD doesn't work, so there's little scientific motivation to run trials on it.

NMN vs NAD: Which Is Better?

So, should you take NAD or NMN? Here’s a practical comparison between the two in terms of what’s better.

Energy and metabolic function

The Yoshino trial showed improved insulin sensitivity, a direct measure of metabolic efficiency. The Yi and Liao trials showed improved aerobic capacity, which is downstream of better mitochondrial energy production.

IV NAD has anecdotal reports of increased energy, but these are observational and uncontrolled. We should be cautious about claims that IV NAD improves energy in healthy people without human outcome trials to back it.

Verdict: NMN is better-supported.

Insulin sensitivity

Yoshino's trial at 250 mg daily showed clinical improvement in a metabolically at-risk population. No comparable trial exists for oral NAD. This is a significant finding because insulin resistance is a real health problem affecting millions of people and a risk factor for metabolic disease.

Verdict: NMN has the evidence.

Physical performance and aerobic capacity

Yi and Liao showed improvements in VO2 max with 600 mg NMN daily. These are objective measures since you're measuring actual oxygen utilization, not subjective feeling. No equivalent trials exist for oral NAD.

Verdict: Clear advantage to NMN.

Cardiovascular and vascular health

This is one of the areas where animal data is substantial, but human evidence is still developing.

Animal studies in mice have shown NMN supplementation improves endothelial function, reduces arterial stiffness, and increases capillary density in aged animals. The mechanism appears to involve restored SIRT1 signaling in vascular tissue, which improves nitric oxide availability and reduces oxidative stress in blood vessels.

In humans, the strongest published cardiovascular evidence for NAD precursors comes from NR rather than NMN. The Martens et al. 2018 trial showed that 1,000 mg of NR daily for six weeks reduced arterial stiffness in middle-aged and older adults. Direct cardiovascular outcome trials for NMN are limited so far, though the mechanistic overlap suggests similar benefits are biologically plausible.

What this means in practice: if cardiovascular markers are your specific concern, the human evidence is currently stronger for NR than for NMN, even though the broader research pipeline favors NMN. This is one of the few places where the precursor choice could reasonably tilt toward NR rather than NMN.

Verdict: Animal data is strong for NMN. Human cardiovascular data is currently stronger for NR. Both are reasonable choices for someone prioritizing vascular health.

Cognitive function

Both NAD and NMN have suggestive animal data showing potential benefits for brain aging. But human trials in healthy adults specifically measuring cognitive outcomes are limited for both. Animal data is interesting but not sufficient to make specific cognitive claims.

Verdict: Insufficient evidence for both.

Cost, Practicality, and Daily Use

IV NAD infusions cost $250–$1,500 per session. A typical protocol recommends one to three sessions per week, totaling $1,000–$18,000 monthly. These costs are out of reach for most people.

In contrast, oral NMN costs roughly $1–$2 per daily dose, or $30–$60 monthly. You take it at home with no clinic visits.

Over a year, the difference is dramatic. NMN costs $360–$720 annually versus tens of thousands for IV NAD. NMN is also shelf-stable, while NAD degrades more quickly. For long-term support, oral NMN is the realistic option.

Safety Profile: NAD vs NMN

Here’s what scientific data says about the safety profile:

• NMN: Clinical trials have tested NMN at doses up to 1,200 mg daily for 60 days in healthy adults. NMN’s side effects are mild, and its overall tolerability is good. The most commonly reported side effects are mild gastrointestinal effects. Headaches and transient fatigue have been reported but are uncommon. Notably, long-term data spanning multiple years is not yet available.

• Direct NAD: IV NAD infusions frequently cause acute side effects. Flushing, dizziness, nausea, and headaches during infusion are common. IM (intramuscular) NAD injections can cause injection site reactions.

Both NAD and NMN should be avoided by:

• People with a cancer history (NAD supports cellular energy, including cancer cells)

• Pregnant/breastfeeding women

• Those on blood thinners or blood pressure medications without physician consultation

NMN's FDA Status: What Changed in 2025

The FDA excluded NMN from dietary supplement status in 2022 due to ongoing Investigational New Drug research.

But in September 2025, the FDA issued formal letters confirming NMN is a lawful dietary supplement ingredient.

NMN can now be sold openly in the US as a supplement under standard labeling and quality requirements. This removes regulatory uncertainty and signals FDA acceptance of NMN's supplement status.

Should You Take NMN and NAD Together?

It is usually unnecessary since NMN converts to NAD inside your cells.

Taking oral NAD on top of oral NMN adds cost without meaningful benefit.

One niche exception to this is that someone receiving IV NAD for a specific clinical reason might also maintain oral NMN at home between infusions.

That said, TMG (methyl donor support) and resveratrol (SIRT1 activator on the same pathway) pair well with NMN.

NMN vs NR: Why NMN Is the More Direct Option

If you've researched NAD supplementation for any length of time, you've probably come across nicotinamide riboside (NR) alongside NMN. Both are NAD precursors, both are sold as supplements, and both raise blood NAD in human trials.

The question worth answering directly: why focus on NMN over NR?

1. Position in the Pathway

NR sits one metabolic step further upstream than NMN. Your body converts NR into NMN first, and then NMN into NAD. NMN skips that initial conversion.

Whether this matters for outcomes is still being studied, but biochemically, NMN is one step closer to the molecule your cells actually use.

2. Research History

NR has the longer track record. Charles Brenner identified NR as an NAD precursor in 2004, and the most well-known commercial form (Niagen) has been in clinical trials longer than NMN. Tru Niagen's research record alone covers more than 45 peer-reviewed human studies.

3. Recent NMN Evidence

What's changed is the pace of NMN research. Since 2021, NMN has accumulated stronger human evidence for specific outcomes than NR has, including insulin sensitivity in postmenopausal women (Yoshino 2021), aerobic capacity in middle-aged adults (Yi 2022), and sleep quality and walking speed in older adults (Morifuji 2024). NR's strongest human evidence is in cardiovascular markers like arterial stiffness (Martens 2018).

4. Bioavailability is Comparable

Both NMN and NR are reliably absorbed orally. Neither has the bioavailability problem that direct NAD has.

If you're choosing between them, that's not the deciding factor.

How to Choose a Quality NMN Supplement

If you've decided NMN is worth exploring, here are the criteria that explain how to choose an NMN supplement.

• Clinically studied dose: The strongest human evidence uses 250–600 mg NMN daily. Anything below 250 mg is probably subtherapeutic. Anything above 900 mg lacks specific trial validation in humans, though animal data suggest safety at higher doses.

• Purity: Look for products labeled >99% NMN, verified by a Certificate of Analysis (CoA).

• Third-party testing: The most meaningful CoA is one from an independent third party (like NSF, USP, or Informed Choice), not the manufacturer's internal lab.

• Manufacturing standards: GMP (Good Manufacturing Practice) certification and FDA facility registration are baseline requirements.

• Supporting ingredients with rationale: Quality NMN products often include complementary ingredients that match a specific biochemical goal. Trans-resveratrol activates the SIRT1 sirtuins that NAD+ feeds, which means it works on the same pathway from a different angle. BioPerine (black pepper extract) has published data showing it improves polyphenol absorption and was associated with a 14.6% increase in NAD levels when co-administered with NMN in one study. TMG (trimethylglycine) is a methyl donor that supports the methylation cycle, which can become depleted with sustained NMN use.

And here’s what you need to avoid:

• Products marketed as containing "NAD+" that list NAD directly as an ingredient (not bioavailable orally)

• Proprietary blends that don't disclose individual ingredient amounts

• Products without publicly available CoAs

• Any supplement claiming to extend human lifespan

A Note on TMG and Pairing Decisions

You may have seen advice that the "ideal" NMN supplement includes TMG. The reasoning has merit: the NAD salvage pathway consumes methyl groups, and over months of supplementation, methyl donor reserves can become depleted.

Some formulators address this by including TMG directly in the capsule.

The honest truth is that this is a formulation choice, and not a strict requirement. The two main pairing strategies for NMN are:

• NMN + SIRT1 activator (resveratrol): Targets the downstream enzymes that depend on NAD+ to function. This pairing has the most preclinical support for healthy aging endpoints because it addresses both the substrate (NMN→NAD+) and the consumer (sirtuins).

• NMN + methyl donor (TMG): Targets the methylation cycle that sustained NMN use can deplete. This pairing addresses a downstream metabolic concern, not the primary NAD-to-sirtuin axis.

Both approaches are defensible. People taking NMN long-term who are also concerned about methylation status (for example, those on methylated B vitamins or with elevated homocysteine) may want TMG in the same formula or alongside it.

For most users, pairing NMN with a SIRT1 activator like resveratrol and adding a separate TMG supplement if needed offers more flexibility than a fixed combination.

Omre's formula reflects the first approach: 500 mg NMN paired with micronized trans-resveratrol and BioPerine for absorption.

If you want TMG included, products like Innerbody Labs NAD+ Support combine NMN, NR, TMG, and spermidine in one capsule, with the trade-off of a three-capsule serving and a higher price.

Why Third-Party Testing Matters More Than the Label

The case for verified Certificates of Analysis isn't theoretical. In 2021, ChromaDex commissioned an independent laboratory analysis of 22 commercial NMN products available to consumers.

The results were stark: 14 of the 22 products (64%) contained less than 1% of the NMN content stated on the label. Some contained no detectable NMN at all.

A separate 2024 peer-reviewed analysis by researchers at the National University of Singapore tested 18 commercial NMN supplements and found content ranging from 28.6% above the labeled amount to none of the claimed compound being detectable at all.

These aren't outliers. They reflect a category where most products on the market do not contain what they claim. The single best protection a buyer has is a batch-specific Certificate of Analysis from an independent third-party laboratory, available to verify the label before purchase. Without it, you genuinely don't know what's in the bottle, regardless of how the marketing reads.

Frequently Asked Questions

Is it better to take NMN or NAD?

NMN is the better oral option. Oral NAD doesn't raise intracellular NAD because NAD is broken down in the digestive tract. NMN is smaller, uses a dedicated transporter, and converts to NAD in one step.

Is NMN the same as NAD?

No. NMN is the precursor; NAD is the active coenzyme. They're metabolically linked but functionally different.

Does NMN really raise NAD levels in humans?

Yes. Multiple 2021–2025 human trials confirm oral NMN raises blood NAD in a dose-dependent manner. The evidence is solid.

What's the recommended NMN dose?

As per clinical trial data, 250–600 mg daily. Yoshino used 250 mg and showed metabolic benefits. Yi and Liao used 600 mg for aerobic benefits. Doses in this range are well-studied.

How long does NMN take to work?

Blood NAD precursors rise within minutes of absorption in animal studies. In humans, measurable changes in blood NAD appear within hours. Downstream health effects (improved insulin sensitivity, aerobic capacity) manifest within 4–8 weeks, as shown in trials.

Should I get NAD IV therapy or take NMN capsules?

For daily long-term use, oral NMN is practical. IV NAD has a role in specific clinical contexts, but for general longevity maintenance, it's impractical because IV costs far more and requires clinic visits.

Can you take NMN and NAD together?

Usually unnecessary. Oral NMN converts to NAD inside your cells anyway, so adding oral NAD on top doesn't meaningfully increase intracellular NAD levels.

The one exception is someone receiving IV NAD for a specific clinical reason who also maintains daily oral NMN between infusions, which is a niche case under physician supervision rather than a general recommendation.

For most people, picking one (NMN) and supporting it with lifestyle inputs and complementary pairings like resveratrol or TMG is more effective than stacking both.

The Bottom Line

NMN and NAD, or NAD vs NMN, depending on how you've searched it, are related but not interchangeable. From an oral supplementation standpoint, this distinction is decisive: NMN works, NAD doesn't.

The likely mechanism is that NMN is absorbed intact, probably via a dedicated transporter, while NAD is degraded in digestion.

The human trial evidence for NMN has strengthened substantially, with data confirming dose-dependent increases in blood NAD and improvements in metabolic markers, aerobic capacity, and sleep. This is genuine progress.

But it's critical to maintain the distinction between raising a biomarker (blood NAD) and demonstrating a health outcome (extended lifespan). The former is established, and the latter is not proven in humans.

If you're thinking about supporting NAD levels, NMN is the evidence-backed choice.

The best results come from layering NMN onto foundations of regular exercise, quality sleep, good nutrition, and stress management. No supplement is a substitute for these fundamentals.

Finding the Right NMN Product for Your Needs

If you're evaluating NMN supplements, look for products with 250–600 mg of >99% pure NMN per serving, batch-specific Certificates of Analysis, GMP manufacturing, and supporting ingredients like trans-resveratrol and BioPerine.

References

1. McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Experimental Gerontology. 2020;134:110888. Doi: https://doi.org/10.1016/j.exger.2020.110888

2. Grozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism. 2019;1(1):47-57. Doi: https://doi.org/10.1038/s42255-018-0009-4

3. Shade C. The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule. Integrative Medicine: A Clinician’s Journal. 2020;19(1):12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/

4. Su M, Qiu F, Li Y, Che T, Li N, Zhang S. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function. Frontiers in Cell and Developmental Biology. 2024;12. Doi: https://doi.org/10.3389/fcell.2024.1464815

5. Mills KF, Yoshida S, Stein LR, et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism. 2016;24(6):795-806. Doi: https://doi.org/10.1016/j.cmet.2016.09.013

6. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547). Doi: https://doi.org/10.1126/science.abe9985

7. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2022;45(1). doi: https://doi.org/10.1007/s11357-022-00705-1

8. Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition. 2021;18(1). doi: https://doi.org/10.1186/s12970-021-00442-4

9. Masashi Morifuji, Higashi S, Shukuko Ebihara, Nagata M. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience. Published online May 24, 2024. Doi: https://doi.org/10.1007/s11357-024-01204-1

10. Kuerec AH, Wang W, Yi L, et al. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration. Mechanisms of Ageing and Development. 2024;218:111917. Doi: https://doi.org/10.1016/j.mad.2024.111917

11. Henderson JD, Sophia, Chachra SS, Conlon N, Ford D. The use of a systems approach to increase NAD+ in human participants. npj Aging. 2024;10(1). Doi: https://doi.org/10.1038/s41514-023-00134-0

12. Reyna K, Heinzen G, Patel N, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in aging. 2026;7:1652582. Doi: https://doi.org/10.3389/fragi.2026.1652582

13. NMN.com. FDA Reverses Course and Dubs NMN Lawful in Dietary Supplements. Nmn.com. Published 2025. https://www.nmn.com/news/fda-dubs-nmn-lawful-in-dietary-supplements